Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Pepe

Showing results (41-50 of 224) with videos related to

Pageof 23
Sort By:
The Annals of Applied Statistics|November 9, 2013
LOGISTIC REGRESSION ANALYSIS WITH STANDARDIZED MARKERSYing Huang, Margaret S Pepe, Ziding Feng
Statistics in Medicine|March 1, 1991
A qualifier Q for the survival function to describe the prevalence of a transient conditionM S Pepe, G Longton, M Thornquist
Biometrics|April 21, 2001
Prediction using partly conditional time-varying coefficients regression modelsM S Pepe, P Heagerty, R Whitaker
Annals of Internal Medicine|November 20, 2008
Assessing the value of risk predictions by using risk stratification tablesHolly Janes, Margaret S Pepe, Wen Gu
Medical Decision Making : an International Journal of the Society for Medical Decision Making|July 2, 2013
A framework for evaluating markers used to select patient treatmentHolly Janes, Margaret S Pepe, Ying Huang
Minerva Medica|September 22, 1979
[The value of electrophoretic studies of urinary proteins in clinical practice]L Salerno, A Di Sciacca, S Pepe
Biometrics|July 6, 2000
Time-dependent ROC curves for censored survival data and a diagnostic markerP J Heagerty, T Lumley, M S Pepe
Journal of the National Cancer Institute|April 1, 2014
Net risk reclassification p values: valid or misleading?Margaret S Pepe, Holly Janes, Christopher I Li
American Journal of Epidemiology|August 10, 2012
Further insight into the incremental value of new markers: the interpretation of performance measures and the importance of clinical contextKathleen F Kerr, Aasthaa Bansal, Margaret S Pepe
Biometrics|November 17, 2019
Statistical inference for net benefit measures in biomarker validation studiesTracey L Marsh, Holly Janes, Margaret S Pepe
Pageof 23

Showing results (41-50 of 224) with videos related to

Sort By:
Pageof 23
The Annals of Applied Statistics|November 9, 2013
LOGISTIC REGRESSION ANALYSIS WITH STANDARDIZED MARKERSYing Huang, Margaret S Pepe, Ziding Feng
Statistics in Medicine|March 1, 1991
A qualifier Q for the survival function to describe the prevalence of a transient conditionM S Pepe, G Longton, M Thornquist
Biometrics|April 21, 2001
Prediction using partly conditional time-varying coefficients regression modelsM S Pepe, P Heagerty, R Whitaker
Annals of Internal Medicine|November 20, 2008
Assessing the value of risk predictions by using risk stratification tablesHolly Janes, Margaret S Pepe, Wen Gu
Medical Decision Making : an International Journal of the Society for Medical Decision Making|July 2, 2013
A framework for evaluating markers used to select patient treatmentHolly Janes, Margaret S Pepe, Ying Huang
Minerva Medica|September 22, 1979
[The value of electrophoretic studies of urinary proteins in clinical practice]L Salerno, A Di Sciacca, S Pepe
Biometrics|July 6, 2000
Time-dependent ROC curves for censored survival data and a diagnostic markerP J Heagerty, T Lumley, M S Pepe
Journal of the National Cancer Institute|April 1, 2014
Net risk reclassification p values: valid or misleading?Margaret S Pepe, Holly Janes, Christopher I Li
American Journal of Epidemiology|August 10, 2012
Further insight into the incremental value of new markers: the interpretation of performance measures and the importance of clinical contextKathleen F Kerr, Aasthaa Bansal, Margaret S Pepe
Biometrics|November 17, 2019
Statistical inference for net benefit measures in biomarker validation studiesTracey L Marsh, Holly Janes, Margaret S Pepe
Pageof 23